Search results
Pakistan probes distributors of Roche cancer drug after patients go blind
Reuters via AOL· 8 months agoLAHORE, Pakistan (Reuters) -Pakistan said on Monday it was investigating two local distributors of...
Biotech Giant Regeneron Hit As Eylea Gives Ground To Avastin
Investor's Business Daily· 1 year agoBiotech giant Regeneron Pharmaceuticals said Monday that sales of its linchpin Eylea drug in the...
Regeneron (REGN) Down on Ophthalmology Drug Eylea Sales Update
Zacks via Yahoo Finance· 1 year agoShares of Regeneron Pharmaceuticals, Inc. REGN were down 7.69% after the company announced that its...
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 9 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...
Amgen drug extends survival in some inoperable colon cancers
Reuters via Yahoo News· 2 years agoThe following are summaries of some of the cancer research advances being presented the annual...
What This News Means for Merck
Motley Fool· 2 years agoIn combination with Roche's (OTC: RHHBY) bevacizumab (Avastin), Merck's (NYSE: MRK) oncology medicine -- co-owned with AstraZeneca (NASDAQ: AZN) and...
Roche (RHHBY) Q3 Revenues Dip on Lower COVID-19-Related Sales
Zacks via Yahoo Finance· 2 years agoSwiss pharma giant Roche Holding AG’s RHHBY third-quarter revenues declined 6% to CHF 14.7 billion...
Roche shuffles early stage pipeline as it joins obesity rush
BioPharma Dive via Yahoo Finance· 3 months agoRoche is reshaping its early-stage pipeline of experimental drugs, jettisoning eight drug candidates...
Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal
Zacks via Yahoo Finance· 1 year agoRoche Holding AG’s RHHBY performance in 2022 was pretty average, as the demand for COVID-19 products...